NEUROBO PHARMACEUTICALS INC's ticker is NRBO and the CUSIP is 64132R107. A total of 20 filers reported holding NEUROBO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $11,000 | -88.8% | 24,056 | -18.7% | 0.00% | – |
| Q2 2021 | $98,000 | -46.7% | 29,576 | -15.5% | 0.00% | – |
| Q4 2020 | $184,000 | -51.6% | 34,987 | -48.3% | 0.00% | – |
| Q3 2020 | $380,000 | -55.9% | 67,616 | -36.8% | 0.00% | -100.0% |
| Q2 2020 | $861,000 | -33.7% | 106,922 | +5.4% | 0.00% | -66.7% |
| Q1 2020 | $1,299,000 | – | 101,418 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mount Yale Investment Advisors, LLC | 57,425 | $214,000 | 0.02% |
| UBS Group AG | 1,037 | $4,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 371 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 323 | $1,000 | 0.00% |
| NORTHERN TRUST CORP | 24,642 | $92,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 728 | $3,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 60,792 | $226,000 | 0.00% |
| STATE STREET CORP | 15,878 | $59,000 | 0.00% |
| MORGAN STANLEY | 141 | $0 | 0.00% |